Related references
Note: Only part of the references are listed.Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study
Malgorzata Mikulska et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Is (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?
Anahita Rouze et al.
INTENSIVE CARE MEDICINE (2022)
(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial
Frank Bloos et al.
INTENSIVE CARE MEDICINE (2022)
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis
Daniele Roberto Giacobbe et al.
MYCOSES (2022)
Beta-D-Glucan in Patients with Haematological Malignancies
Malgorzata Mikulska et al.
JOURNAL OF FUNGI (2021)
Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study
Joveria Farooqi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis
Antonios Kritikos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial
Gennaro De Pascale et al.
CRITICAL CARE (2020)
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Ignacio Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2019)
Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa
Vindana Chibabhai et al.
MYCOSES (2019)
Diagnosis of Fungal Infections A Systematic Review and Meta-Analysis Supporting American Thoracic Society Practice Guideline
Qusay Haydour et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies
Thomas F. Patterson et al.
JOURNAL OF FUNGI (2019)
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units
Daniele Roberto Giacobbe et al.
CRITICAL CARE (2017)
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis
M. Mikulska et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions
Cristobal Leon et al.
CRITICAL CARE (2016)
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis
Estrella Martin-Mazuelos et al.
INTENSIVE CARE MEDICINE (2015)
Candida biomarkers in patients with candidaemia and bacteraemia
M. Carmen Martinez-Jimenez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
β-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)
Frederic Lamoth et al.
CLINICAL INFECTIOUS DISEASES (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Drosos E. Karageorgopoulos et al.
CLINICAL INFECTIOUS DISEASES (2011)